Literature DB >> 21922233

Echocardiography versus intracardiac electrocardiography-based optimization for cardiac resynchronization therapy : a comparative clinical long-term trial.

C J Jensen1, A Liadski, M Bell, C K Naber, O Bruder, G V Sabin, B Küpper, H Wieneke.   

Abstract

BACKGROUND: Optimization of AV and VV delay programming has been shown to be essential for the success of cardiac resynchronization therapy (CRT). Acute hemodynamic improvement can be obtained by intracardiac electrocardiogram (IEGM)-based optimization. The aim of the present study was to evaluate whether this IEGM-based algorithm is comparable to the current gold standard of echocardiography.
METHODS: After device implantation patients with standard criteria for CRT, AV and VV delay programming was either optimized by an IEGM-based algorithm (IEGM group, n = 24) or by echocardiography (echo group, n = 24). Cardiopulmonary exercise capacity was assessed after 3 and 12 months on the basis of NYHA class and the 6-min-walk test. Left ventricular ejection fraction was evaluated by echocardiography.
RESULTS: In both groups there was a significant decrease in NYHA class and a significant increase in 6-min-walk distance and ejection fraction after 3 and 12 months. After 12 months there was no significant difference in the proportion of responders, NYHA class and 6-min-walk distance between the IEGM the echo group.
CONCLUSION: The present data show that a sustained improvement of cardiopulmonary exercise capacity can be obtained by optimizing CRT patients on the basis of an IEGM algorithm. The comparable results for cardiopulmonary exercise parameters suggest that this new method might become an important tool for adjusting CRT programming in daily practice.

Entities:  

Mesh:

Year:  2011        PMID: 21922233     DOI: 10.1007/s00059-011-3507-7

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  33 in total

1.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

2.  Primary results from the SmartDelay determined AV optimization: a comparison to other AV delay methods used in cardiac resynchronization therapy (SMART-AV) trial: a randomized trial comparing empirical, echocardiography-guided, and algorithmic atrioventricular delay programming in cardiac resynchronization therapy.

Authors:  Kenneth A Ellenbogen; Michael R Gold; Timothy E Meyer; Ignacio Fernndez Lozano; Suneet Mittal; Alan D Waggoner; Bernd Lemke; Jagmeet P Singh; Francis G Spinale; Jennifer E Van Eyk; Jeffrey Whitehill; Stanislav Weiner; Maninder Bedi; Joshua Rapkin; Kenneth M Stein
Journal:  Circulation       Date:  2010-11-15       Impact factor: 29.690

3.  Relative contribution of resting haemodynamic profile and lung function to exercise tolerance in male patients with chronic heart failure.

Authors:  P Faggiano; A D'Aloia; A Gualeni; A Giordano
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

Review 4.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

5.  The effect of cardiac resynchronization on morbidity and mortality in heart failure.

Authors:  John G F Cleland; Jean-Claude Daubert; Erland Erdmann; Nick Freemantle; Daniel Gras; Lukas Kappenberger; Luigi Tavazzi
Journal:  N Engl J Med       Date:  2005-03-07       Impact factor: 91.245

6.  Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up.

Authors:  Cinzia Valzania; Mauro Biffi; Cristian Martignani; Igor Diemberger; Matteo Bertini; Matteo Ziacchi; Letizia Bacchi; Guido Rocchi; Claudio Rapezzi; Angelo Branzi; Giuseppe Boriani
Journal:  Echocardiography       Date:  2007-10       Impact factor: 1.724

7.  Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program.

Authors:  Wilfried Mullens; Richard A Grimm; Tanya Verga; Thomas Dresing; Randall C Starling; Bruce L Wilkoff; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2009-03-03       Impact factor: 24.094

8.  A real-time three-dimensional echocardiographic validation of an intracardiac electrogram-based method for optimizing cardiac resynchronization therapy.

Authors:  Maria Cristina Porciani; Carmelo Massimiliano Rao; Matteo Mochi; Francesco Cappelli; Gabriella Bongiorno; Alessandro Paoletti Perini; Alessio Lilli; Giuseppe Ricciardi; Lawrence Hashtroudi; Paolo Silvestri; S Serge Barold; Luigi Padeletti
Journal:  Pacing Clin Electrophysiol       Date:  2008-01       Impact factor: 1.976

9.  Optimization of AV and VV delays in the real-world CRT patient population: an international survey on current clinical practice.

Authors:  Daniel Gras; Manish S Gupta; Eric Boulogne; Lisa Guzzo; William T Abraham
Journal:  Pacing Clin Electrophysiol       Date:  2009-03       Impact factor: 1.976

10.  Reliability of a novel intracardiac electrogram method for AV And VV delay optimization and comparability to echocardiography procedure for determining optimal conduction delays in CRT patients.

Authors:  N Reinsch; C Buhr; S Huptas; T Buck; T Konorza; H Wieneke; R Erbel
Journal:  Indian Pacing Electrophysiol J       Date:  2009-03-15
View more
  1 in total

Review 1.  Resynchronization Therapy for Patients with Congenital Heart Disease: Are We Ready for Prime Time?

Authors:  Scott Anjewierden; Peter F Aziz
Journal:  Curr Cardiol Rep       Date:  2018-07-18       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.